The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies

Abstract The aim of the study is to compare the efficacy of SPIO as a tracer in sentinel node biopsy (SNB) in breast cancer with Tc and patent blue in a multicentre prospective study and perform a meta-analysis of all published studies. It also aims to follow skin discoloration after SPIO injection and describe when and how it resolves. Totally 206 patients with early breast cancer were recruited. Tc and patent blue were administered in standard fashion. Patients were injected with SPIO (Sienna+) preoperatively. SNB was performed and detection rates were recorded for both methods. Skin discoloration was followed and documented postoperatively. Data extraction and subsequent meta-analysis of all previous studies were also performed. SN detection rates were similar between standard technique succeeded and SPIO both per patient (97.1 vs. 97.6 %, p = 0.76) as well as per node (91.3 vs. 93.3 %, p = 0.34), something which was not affected by the presence of malignancy. Concordance rates were also consistently high (98.0 % per patient and 95.9 % per node). Discoloring was present in 35.5 % of patients postoperatively, almost exclusively in breast conservation. It fades slowly and is still detectable in 8.6 % of patients after 15 months. Meta-analysis depicted similar detection rates (p = 0.71) and concordance rates (p = 0.82) per patient. However, it seems that SPIO is characterized by higher nodal retrieval (p < 0.001). SPIO is an effective method for the detection of SN in patients with breast cancer. It is comparable to the standard technique and seems to simplify logistics. Potential skin discoloration is something of consideration in patients planned for breast conservation.

[1]  J. Geraghty,et al.  The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733). , 2015, Annals of surgery.

[2]  J. M. Román-Santamaría,et al.  Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: A comparative non-inferiority study. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  P. Rucci,et al.  The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment , 2017, European journal of cancer care.

[4]  Joost J. Pouw,et al.  Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model , 2013, Breast Cancer Research and Treatment.

[5]  G. Govaert,et al.  Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  A. Derossis,et al.  Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.

[7]  N. Hauser,et al.  The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. , 2014, Breast.

[8]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[9]  PhD Ebsq Frcs Vassilis Pitsinis MD,et al.  Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer , 2017, Annals of Surgical Oncology.

[10]  Q. Pankhurst,et al.  Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial , 2014, Annals of Surgical Oncology.

[11]  A. Purushotham,et al.  Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. , 2014, The Lancet. Oncology.

[12]  A. Tutt,et al.  Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer , 2012, Annals of Surgical Oncology.

[13]  E. Rutgers,et al.  UvA-DARE ( Digital Academic Repository ) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS , 2010 .

[14]  PhD Kazuyoshi Motomura MD,et al.  SPIO-Enhanced Magnetic Resonance Imaging for the Detection of Metastases in Sentinel Nodes Localized by Computed Tomography Lymphography in Patients with Breast Cancer , 2011, Annals of Surgical Oncology.

[15]  K. Hunt,et al.  Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis , 2016, Annals of Surgical Oncology.

[16]  Q. Pankhurst,et al.  Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[17]  K. Slim,et al.  Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument , 2003, ANZ journal of surgery.

[18]  V. Speirs,et al.  Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  I. Rubio,et al.  The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  M. Carr,et al.  Sentinel lymph node biopsy in early breast cancer surgery--working with the risks of vital blue dye to reap the benefits. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  F. Guillemin,et al.  Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial , 2016, Journal of surgical oncology.

[22]  M. Somerfield,et al.  Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Axelrod,et al.  Patterns of Axillary Surgical Care for Breast Cancer in the Era of Sentinel Lymph Node Biopsy , 2009, Annals of Surgical Oncology.

[24]  N. Sata,et al.  Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study , 2014, Breast Cancer.

[25]  Kei Aoyama,et al.  Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green , 2011, World journal of surgical oncology.

[26]  P. Dionigi,et al.  Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer , 2006, Expert review of anticancer therapy.

[27]  C. Teo,et al.  Blue dye is sufficient for sentinel lymph node biopsy in breast cancer , 2014, The British journal of surgery.

[28]  Moriaki Kusakabe,et al.  Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer , 2013, Breast Cancer.

[29]  Joost J. Pouw,et al.  Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol. , 2015, The British journal of radiology.

[30]  S. Singletary,et al.  Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  A. C. Brown,et al.  Allergic reactions to isosulfan blue during sentinel node biopsy--a common event. , 2001, Surgery.

[32]  J. Olliver,et al.  Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus , 2003, The Lancet.

[33]  Joost J. Pouw,et al.  Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model , 2015, International journal of nanomedicine.